CHATHAM CAPITAL GROUP, INC. - J P MORGAN EXCHANGE-TRADED F ownership

J P MORGAN EXCHANGE-TRADED F's ticker is JPST and the CUSIP is 46641Q837. A total of 695 filers reported holding J P MORGAN EXCHANGE-TRADED F in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
CHATHAM CAPITAL GROUP, INC. ownership history of J P MORGAN EXCHANGE-TRADED F
ValueSharesWeighting
Q3 2023$10,380,335
+45.0%
206,862
+44.9%
2.32%
+53.9%
Q2 2023$7,158,087
+4.9%
142,762
+5.2%
1.51%
-1.3%
Q1 2023$6,826,512
-1.8%
135,662
-2.1%
1.53%
-6.4%
Q4 2022$6,950,123
-1.9%
138,642
-1.8%
1.63%
-6.2%
Q3 2022$7,084,000
-5.2%
141,235
-5.4%
1.74%
+2.7%
Q2 2022$7,476,000
-2.8%
149,250
-2.5%
1.69%
+13.7%
Q1 2022$7,694,000
+2.0%
153,060
+2.4%
1.49%
+9.3%
Q4 2021$7,544,000
-3.0%
149,450
-2.5%
1.36%
-9.0%
Q3 2021$7,776,000
+0.3%
153,315
+0.3%
1.50%
-0.1%
Q2 2021$7,756,000
+2.7%
152,855
+2.7%
1.50%
-5.2%
Q1 2021$7,553,000
+2.2%
148,805
+2.3%
1.58%
-4.8%
Q4 2020$7,388,000
+7.3%
145,465
+7.3%
1.66%
-2.1%
Q3 2020$6,883,000
+36.5%
135,510
+36.4%
1.70%
+30.0%
Q2 2020$5,041,000
+16.4%
99,375
+14.0%
1.30%
+2.1%
Q1 2020$4,330,000
+39.7%
87,175
+41.9%
1.28%
+67.3%
Q4 2019$3,099,000
+91.8%
61,445
+91.7%
0.76%
+85.0%
Q3 2019$1,616,000
+25.1%
32,045
+25.0%
0.41%
+27.1%
Q2 2019$1,292,000
+7.1%
25,645
+6.9%
0.32%
+4.8%
Q1 2019$1,206,00023,9800.31%
Other shareholders
J P MORGAN EXCHANGE-TRADED F shareholders Q3 2021
NameSharesValueWeighting ↓
Sanctuary Wealth Management, L.L.C. 742,470$37,190,00045.59%
ACT Advisors, LLC. 812,844$40,715,00029.85%
FOSTER DYKEMA CABOT & CO INC/MA 3,924,182$196,562,00024.25%
Requisite Capital Management, LLC 1,329,285$66,584,00022.12%
Magnolia Wealth Management, LLC 368,681$18,467,00020.93%
Cornerstone Management, Inc. 1,568,601$78,571,24620.43%
Paradigm Capital Management, LLC/NV 297,420$14,898,00018.72%
Reitz Capital Advisors LLC 384,229$19,246,00017.23%
Smart Portfolios, LLC 162,077$8,127,00016.42%
McCarthy Asset Management, Inc. 397,372$19,904,00016.20%
View complete list of J P MORGAN EXCHANGE-TRADED F shareholders